Trade Summary

6 days ago, Gault Cheryl, serving as COO at Rapport Therapeutics, Inc. (RAPP), sold 10,000 shares at $28.19 per share, for a total transaction value of $281,857.00. Following this transaction, Gault Cheryl now holds 159,914 shares of RAPP.

This sale represents a 6.00% decrease in Gault Cheryl's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 30, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 31, 2026, 1 day after the trade was made.

Rapport Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.